1 / 4

The global pharmaceutical industry

STRATEGIC MANAGEMENT. The global pharmaceutical industry. PESTEL. Political Government are powerful purchasers Government price control Different coverage and reimbursement systems between countries. Economic 1960’ s pharmaceutical industry prospered (light regulatory control)

arnon
Télécharger la présentation

The global pharmaceutical industry

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. STRATEGIC MANAGEMENT The global pharmaceutical industry Irina Raynaud Pierre Jean Tessier Nicolas Cabrit Clément Tumoine

  2. PESTEL • Political • Government are powerful purchasers • Government price control • Different coverage and reimbursement systems between countries • Economic • 1960’ s pharmaceutical industry prospered (light regulatory control) • 80% of the market is owned by 5 countries (USA, Japan, EU, China and Mexico) • Blockbuster power • China and India = attractive countries for global manufacturing and RD investments • Sales and Marketing important part in competitive advantage • 1990’s economic recession • Sociocultural • - Average life expectancy increased by over 20 years • - Consumers are well informed thanks the to the easier information access (internet) • Social coverage are different in many countries • No-profit basis operation in order to help undeveloped countries

  3. Technological • R&D is more efficient => importance of the innovation • New type of industry based on new projects: biotechnology • Speed of technologic transfer in developing countries • Environmental • Biopharmaceutical takes a more important place and become mainstream( many companies invest in this new sector) • Legal • Tighter regulatory control since thalidomide issue • Legislation set a fixed period on patent protection : 20 years from initial filling • Creation of institutions in order to regulate the international regulation harmonization (EMEA in Europe, International Conference Harmonization in USA, Food and Drug Administration) • Medicare reform in 2006 (drug coverage for elderly people) • Legislation proposition about allowing generic imports and branded drugs in South Africa

  4. Key drivers :- R&D - Sales and Marketing - Arrival of new pharmaceutical sectors: generics, biotechnologies, OTC medicines (force companies to invest and innovate) - Blockbusters Major trends:- Conglomerate companies (mergers and acquisitions) - Pharmaceutical companies manage to be both creative and efficient (by increasing R&D power) - The latest trend : invest in biopharmaceutical area

More Related